Stock Updates

Eli Lilly and Company (NYSE: LLY) – Is this large market cap stock undervalued?

Eli Lilly and Company (NYSE: LLY), is firmly in the large market cap category with market cap of 89090.93. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Eli Lilly and Company is 80.71 (with a change from open of -0.16%), this in conjunction with a target price of 97.5. Volume today has so far reached 2466200, with an average volume of about 3504.95. The GAP for this stock, is -0.05%.

The P/E ratio is 34.79, bringing the forward P/E to a value of 19.73. The current EPS for Eli Lilly and Company, is 2.32, with a EPS growth for this year coming to a value of 1.60%. Performance has been interesting with performance year to date coming to -2.28%.

Looking further into the growth statistics for Eli Lilly and Company, EPS is looking like it will grow 13.96% in the next year. Looking even further it is projected to be 13.06%. Quarter over quarter is 25.10% for EPS growth and for sales growth quarter over quarter it is 8.60%. Looking at past EPS growth statistics we see that for the past five years it has been -13.20%. Sales growth for the past five years has in fact been -2.90%.

Looking at the ownership, we see that the insider ownership is at 11.40% and institutional ownership is 77.10%. Shares outstanding is 1103.84, while shares float is at a value of 1101.58. Float short for Eli Lilly and Company is 0.55% and the short ratio is 1.72.

In terms of debt, long term debt/equity is 0.59, while the total debt/equity comes to 0.64. The ability to meet these debts, means that the current ratio is 1.5, and the quick ratio is 1.1. The most recent gross margin is 73.70% and their operating margin is 14.60%. The profit margin is 12.00%.

Eli Lilly and Company has seen returns on assets of 6.90%, and on investment, 9.50%. Return on equity is 16.60%. Price/Earnings to growth ratio is 2.66. Price/Sales ratio is at a value of 4.32, with Price/book ratio coming to 5.83 and Price/cash is 22.64, and finally Price/Free cash Flow is *TBA.

The simple moving averages are 0.97% and 5.12% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -6.61% and the 52 week low is 20.46%.

Eli Lilly and Company has a dividend yield of 2.53%, with a current price of 80.71. The ability to pay this means the payout ratio is 91.20%. This is in an industry, Drug Manufacturers – Major, with equally high dividends from other companies in this sector, which it is Healthcare. Eli Lilly and Company is based in USA.

Performance in the Drug Manufacturers – Major industry means that Eli Lilly and Company has seen performance for the past week of -0.20%, with performance for the month coming to 2.68%. Looking at the data for the quarter it is at a value of 3.93%, and for the half year the performance is 3.21%. Volatility for this week is 1.39% and for the month this is 1.38%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment